Acute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations
|
|
- Georgiana Little
- 6 years ago
- Views:
Transcription
1 Acute Isolated Pulmonaw Reiection Following Transplantatich of the Heart and Both Lungs: Experimental and Clinical Observations D. Novitzky, M.D., D. K. C. Cooper, Ph.D., F.R.C.S., A. G. Rose, Ch.B., M.Med.(Path), M.R.C.(Path), and B. Reichart, M.D. ABSTRACT Early observations following transplantation of the heart and both lungs have suggested that acute rejection occurs simultaneously in both organs. Endomyocardial biopsy could, therefore, be used to monitor rejection in both heart and lungs. We present here our experience with heart-lung transplantation in the baboon, and in two recently observed human patients. The evidence we provide suggests that acute rejection may occur earlier in the lungs than in the heart, and that monitoring the heart alone may prove inadequate. Of 12 baboons that survived heart and lung transplantation, 11 died from acute isolated pulmonary rejection; 10 of these 11 animals showed no features of cardiac rejection. In 2 of 6 human patients who have undergone this operation, an episode of acute pulmonary rejection is believed to have occurred in the absence of cardiac rejection. There is no easy method of confirming pulmonary rejection directly (other than open-lung biopsy, which is clearly contraindicated as a routine procedure). We suggest that more attention be directed toward developing tests that indicate acute rejection but are not organ specific, rather than relying on techniques that diagnose cardiac rejection only. Transplantation of the heart and both lungs is the logical therapy for patients with primary hypertension or Eisenmenger syndrome accompanied by end-stage rightheart failure [l-61. Early observations by Reitz and colleagues [7] suggested that the heart showed evidence of rejection whenever the lungs were undergoing acute rejection. Endomyocardial biopsy [8] could, therefore, be used to monitor rejection in both heart and lungs. At least 1 human patient, however, has been reported in whom severe pulmonary rejection was not associated with cardiac rejection [9], and a similar observation has been made in 2 experimental animals [lo]. We present here our experience with heart-lung transplantation in the baboon, and in 2 recently observed From the Departments of Cardiothoracic Surgery and Pathology, Groote Schuur Hospital and the University of Cape Town Medical School, Cape Town, South Africa. Accepted for publication Nov 19, Address reprint requests to Dr. Novitzky, Department of Cardiothoracic Surgery, University of Cape Town Medical School, Cape Town, South Africa. human patients. We also provide evidence to suggest that acute rejection occurs earlier in the lungs than in the heart, and that monitoring of the heart alone may therefore prove inadequate. Experimental Study Fourteen chacma baboons, weighing 25 to 27 kg each, underwent transplantation of the heart and both lungs from donor baboons matched for size and AB blood group. The techniques of excision of the donor and recipient organs and of implantation of the allografts were as described by Reitz and by Jamieson and colleagues [ 1, 21 and have been fully described elsewhere. In both experimental studies and clinical cases, the lungs were preserved by low-pressure (50 cm H20) infusion of Euro Collins solution with 50 ml of 50% dextrose added, and the heart was preserved by infusion of the cardioplegic solution used by Wicomb and co-workers [ll]; both organs were topically cooled with saline at 4 C. The 14 baboons received one of three immunosuppressive regimens (Table); cyclosporin A was given daily, either orally or by a single intravenous (IV) injection, or it was given twice daily by intravenous injections. Cyclosporin trough levels were measured in whole blood and were found to be below the ideal therapeutic levels in all animals (less than 100 ng/ml). No attempt was made to treat suspected acute rejection. Monitoring consisted of daily recording of electrocardiogram data, rectal temperature, arterial blood gas tension, complete blood count, and liver function test results. Chest roentgenograms were taken at intervals in selected animals. Elevation of the temperature, a fall in the arterial oxygen tension (Pa02), and patchy shadowing on chest roentgenograms were thought to indicate acute rejection of the lungs. No monitoring for rejection of the heart by endomyocardial biopsy or radionuclide scanning [12] was performed. Res u 1 ts Twelve of the 14 baboons survived between 4 and 29 days (Table). When death occurred, it resulted from acute pulmonary rejection in 11 and from bronchopneumonia in 1. In 11 animals, the lungs showed histologic evidence of severe acute rejection, including prominent perivascular and interstitial infiltrates of lymphocytes and plasma cells (Figs 1-3). Interstitial and intraalveolar edema was also noted. These changes resulted in greatly thickened 180 Ann Thorac Surg 42: , Aug 1986
2 181 Novitzky, Cooper, Rose, et al: Pulmonary Rejection after Heart-Lung Transplant lmmunosuppressive Regimens and Survival Times in 12 Chacma Baboons Undergoing Allotransplantation of the Heart and Both Lungs Immunosuppressive Therapy (mg/kg) Allograft Survival No. of Baboons Cyclosporin A Azathioprine Methylprednisolone (days) 4a 4 4 Wday, orally 18/day, by single IV injection 2-4iday orally for first 2 weeks 2iday from beginning of week 3 18, by twice daily IV injection "Two further baboons died as a result of technical problems. IV = intravenous. 6, 6, 19, 29 (mean, 15) 7, 12, 19, 20 (mean 15) 4, 5, 20, 28 (mean, 14) Fig I. Acute rejection of donor lung is manifested by a perivascular cellular infiltrate composed of lymphocytes and plasma cells that are spreading out into the adjacent alveolar septa. (H6E; x 250). Fig 3. Higher-power magnification of the lymphoid infiltrate in an alveolar septum of the rejection lung shown in Figure 2. (HBE; X 600). Clinical Experience The early clinical course of 2 of our 6 human patients (4 in Cape Town and 2 in Munich) who underwent transplantation of the heart and both lungs is described briefly as follows. Fig 2. Photomicrograph showing acute pulmonary rejection. Severe widening of the alveolar septa by the cellular infiltrate has led to reduction in size of the air spaces. (H&E; x 250). alveolar septa and, consequently, reduced alveolar aircarrying capacity (Fig 2). Only 1 of these animals showed any features of acute cardiac rejection; this baboon's heart had sparse focal infiltrates of pyroninophilic lymphocytes in the edematous interstitium, indicating mild rejection. The remaining 10 animals showed no features of cardiac rejection. Patient 1 This patient was a 27-year-old woman with underlying primary pulmonary hypertension who underwent transplantation in June, Initial immunosuppression consisted of oral cyclosporin A to maintain trough levels at approximately 400 ng/ml and oral azathioprine at 1.5 to 2.0 mg/kg daily. Ten days after transplantation a pyrexia of 38 C developed, associated with a reticular pattern visible in the lung fields on chest roentgenograms (Fig 4). Cytological monitoring, using a method developed in Munich [13], showed the presence of activated lymphoblasts, which suggests acute rejection. One day later she became moderately dyspneic, although her blood gas tension remained normal. Klebsiella spp. were cultured from her sputum, and she was given a course of tobramycin and subsequently amikacin. Within 4 days her sputum became sterile, but her symptoms of pyrexia, dyspnea, and cough persisted, and the
3 182 The Annals of Thoracic Surgery Vol 42 No 2 August 1986 A B Fig 4. Posteroanterior chest roentgenogram of patient I: (A) 27 days after transplantation of the heart and both lungs and (B) 4 days after ant ireject ion therapy. shadowing on the chest roentgenogram became more marked. On day 17 posttransplant her respiratory rate increased and Pa02 fell to 9 kpa (67.5 mm Hg) from a previous level of 10 to 12 kpa when she was breathing room air. She required oxygen therapy by mask. Radionuclide scanning (121 and endomyocardial biopsy (Fig 5) showed no features of myocardial rejection. Monoclonal antibodies used on frozen sections of the biopsy to investigate lymphocyte subpopulations revealed only a few T8 cytotoxic/suppressor lymphocytes, no inducer1 Fig 5. Histological section of endomyocardial biopsy done on patient I on day 17 after transplantation of the heart and both lungs, showing no signs of cardiac rejection. helper T cells, and no B cells, macrophages, or neutrophils. Intensive investigations for a source of bacterial, fungal, or viral infection proved negative. The patient's clinical condition was deteriorating. This fact, together with the findings on the chest roentgenogram and the presence of activated lymphocytes on cytological monitoring [ 131, suggested the possibility of acute rejection of the lungs, despite the absence of any features of rejection of the heart. She was therefore given a course of IV methylprednisolone (MP), 1 gm daily for 4 days, beginning on day 17. Within 6 hours of the first 1-gm infusion, she showed symptomatic improvement, becoming less dyspneic; her Pa02 rose to 12 kpa. Within 24 hours she was afebrile. On day 18, administration of oral MP was begun (0.3 mg/kg daily). Within 5 days the lung fields as seen on the chest roentgenogram were almost clear. The activated lymphocytes disappeared from her blood. She then remained afebrile and asymptomatic for 2 days, after which she again had a pyrexia of 39 C and had a pleuritic rub. Radionuclide scanning and endomyocardial biopsy were again normal, and on this occasion both the chest roentgenogram and cytological monitoring showed no abnormalities. Because acute pulmonary rejection was thought to be continuing, she was given a course of IV rabbit antithymocyte globulin (RATG; 2 mg/kg daily for 3 days) and MP (1 gm on the first day and 500 mg daily for 2 further days). Throughout this period cyclosporin A levels remained in the low therapeutic range. Patient 2 This patient, a 20-year-old man, underwent transplantation in August, 1985, for underlying idiopathic pulmonary hypertension and right ventricular failure.the basic immunosuppressive regimen was the same as that for patient 1. His initial progress was uneventful, although
4 183 Novitzky, Cooper, Rose, et al: Pulmonary Rejection after Heart-Lung Transplant he required vigorous physiotherapy and repeated therapy with continuous positive airway pressure to expand both lung bases. On day 6 postoperation, a pyrexia of 39"C, sweating, and a cough developed that continued intermittently for the next 24 hours, during which all investigations for a source of infection proved negative. He became dyspneic, and his PaOz fell from 12 to 9 kpa during the course of 24 hours. A chest roentgenogram showed patchy shadowing throughout both lungs. In the absence of any confirmation of infection, he was treated with MP (1 gm IV) and with k4tg (2.5 mglkg IV), and then with further MP (1 gm) and RATG (1 to 2 mg/kg) therapy on days 7 and 8. Within hours of the initial antirejection therapy, his symptoms had markedly improved. By day 8 his PaOz had risen to 11 kpa, and his chest roentgenogram had virtually cleared. It was not until day 9 that an endomyocardial biopsy was performed. This showed no substantial features of acute rejection whatsoever. (It was our opinion that if cardiac rejection had been taking place during the previous 3 days, some histopathological features would still have been present on day 9. In particular we would expect the presence of residual mononuclear cells.) On day 10 he once again became tachypneic and febrile (38.5"C). On this occasion, however, his chest roentgenogram showed no deterioration, and he became cold peripherally, which suggests a low cardiac output. He was given a further 3-day course of MP (1 gm daily IV), and on day 11 he also received RATG (2 mg/kg IV). Once again his symptoms subsided. Radionuclide scanning of the heart, performed during this suspected episode of cardiac rejection, showed a reduction in stroke volume, which would strongly support this diagnosis. Subsequent scanning on day 17 showed recovery of left ventricular volumes and function. He then remained well until day 27, when again a pyrexia developed and showed a generalized reticular pattern in both lung fields on a chest roentgenogram. Radionuclide scanning at this stage again showed reduced stroke volume, and it was thought that on this occasion the patient showed features of both pulmonary and cardiac acute rejection. He received a further course of MP to which he responded well. His subsequent course has been uneventful. Comment The difficulty of maintaining adequate blood levels of cyclosporin A in the baboon has hindered our transplantation research program, as exemplified by the high incidence of acute rejection in the baboons in the present study. Even the twice-daily administration of intravenous cyclosporin in relatively high doses was insufficient to maintain whole-blood trough levels in the desired therapeutic range (200 to 400 ng/ml). The low blood level achieved by the oral administration of this drug is probably species related, because good blood levels are achieved in most other animal species, including humans. In the baboon it seems likely that gastrointestinal tract absorption is impaired, or there is rapid excretion of the drug by the liver, or both. Recent work in our laboratory has shown, however, that adequate trough levels can be attained by daily intramuscular injection of cyclosporin A, administered in a mixture of alcohol and intralipid substances [14]; this development will greatly facilitate transplantation studies in the baboon. The experimental observations presented here clearly indicate that, in the inadequately immunosuppressed baboon, acute rejection of the lung occurs earlier than rejection of the heart. Pulmonary rejection in the absence of cardiac rejection, and vice versa, has also been documented in a small number of cynomolgus monkeys [lo]. Lung rejection has been shown by Prop and colleagues [15] to occur at an earlier stage than heart rejection in rats receiving no immunosuppression; their study suggests that lymphoid tissue transplanted within the lungs is an important stimulus that makes the unmodified rejection of lungs more vigorous than that of hearts. The two case histories described here also indicate that, on occasion, pulmonary rejection may be more vigorous than cardiac rejection. A similar observation has been made by others in 1 patient [9]. From these experimental and clinical observations we conclude that, where pneumonia has been excluded (as far as possible) by investigation, acute rejection of the lungs must always be strongly suspected if there are any suggestive features. One such feature of particular importance is pulmonary shadowing seen on chest roentgenograms despite normal results of endomyocardial biopsy (indicating no acute rejection of the heart). It seems possible that episodes of pulmonary shadowing on chest roentgenograms, previously termed a "reimplantation response" because of the absence of any evidence of heart rejection in the results of endomyocardial biopsy, may in reality be episodes of reversible acute rejection of the lungs, particularly if they occur after the first postoperative week. Possibly a greater degree of suspicion with regard to the development of acute pulmonary rejection is necessary than was previously thought. (These observations agree with those made at Stanford Medical Center, Stanford, CA; [S. Jamieson, personal communication].) In the absence of any easy method of confirming pulmonary rejection directly (other than open-lung biopsy, which is clearly contraindicated as a routine procedure), more attention should be directed toward developing tests that indicate acute rejection but are not organ specific. Such tests include cytological immunological monitoring [13] or the neopterin test [16], as opposed to techniques that diagnose cardiac rejection only. References 1. Reitz BA: Heart-lung transplantation: a review. Heart Transplant 1:291, Jamieson SW, Baldwin JC, Reitz BA, et al: Combined heart and lung transplantation. Lancet 1:1130, Novitzky D, Cooper DKC, Wicomb WN, et al: Transplanta-
5 1% The Annals of Thoracic Surgery Vol 42 No 2 August 1986 tion of the heart and both lungs: experimental and clinical experience and review of the literature. S Afr Med J 67:575, Reichart B, Reble B, Kemkes BM, et al: The first two heartlung transplants in Germany. MMW 126:1355, McGregor CGA, Jamieson SW: Clinical heart and lung transplantation. Br Med J 290:1682, Novitzky D, Cooper DKC: Transplantation of the heart and both lungs. In Cooper DKC, Lanza RP (eds): Heart Transplantation. Lancaster, England, MTP Press, 1984, pp Reitz BA, Gaudiani VA, Hunt SA, et al: Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. J Thorac Cardiovasc Surg 85:354, Caves PK, Stinson EB, Graham AF, et al: Percutaneous transvenous endomyocardial biopsy. JAMA 225:288, McGregor CGA, Baldwin JC, Jamieson SW, et al: Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg (in press) 10. Scott WC, Haverich A, Billingham ME, et al: Lethal rejection of the lung without significant cardiac rejection in primate heart-lung allotransplants. Heart Transplant 4:33, Wicomb WN, Cooper DKC, Novitzky D, Barnard CN: Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg 37:243, Novitzky D, Boniaszczuk J, Cooper DKC, et al: Prediction of acute cardiac rejection using radionuclide techniques. S Afr Med J 65:5, Hammer C, Reichenspurner H, Ertel W, et al: Cytological and immunologic monitoring of cyclosporine-treated human heart recipients. Heart Transplant 3:228, Novitzky D, Cooper DKC, Wicomb WN: A successful method of administering cyclosporin A to the chacma baboon. S Afr Med J 66:737, Prop J, Kuijpers K, Nieuwenhuis P, Wildevuur CRH: Why are lung grafts rejected more vigorously than heart grafts? Paper presented at the 5th Annual Scientific Session of the International Society for Heart Transplantation, March, Heart Transplant 4:143, 1985 (Abstract) 16. Margreiter R, Fuchs D, Husen A, et al: Neopterin as a new biochemical marker for diagnosis of allograft rejection: experience based upon evaluation of 100 consecutive cases. Transplantation 36:650, 1983
158 Ann Thorac Surg 45: , Feb Copyright by The Society of Thoracic Surgeons
Value of Urinary Polyamines as Noninvasive Markers of Cardiac Allograft Rejection in the Dog Michel Carrier, M.D., Diane H. Russell, Ph.D., Thomas P. Davis, Ph.D., Robert W. Emery, M.D., and Jack G. Copeland,
More informationMODERATOR Felix Rapaport, other members of this
The First Lung Transplant in Man (1963) and the First Heart Transplant in Man (1964) J.D. Hardy MODERATOR Felix Rapaport, other members of this distinguished panel, and members of the audience, I will
More informationHuman Heart Transplantation: Current Status
Human Heart Transplantation: Current Status Randall B. Griepp, M.D., Edward B. Stinson, M.D.," Charles P. Bieber, M.D., Bruce A. Reitz, M.D., Jack G. Copeland, M.D., Philip E. Oyer, M.D., and Norman E.
More informationRight-Sided Bacterial Endocarditis
New Concepts in the Treatment of the Uncontrollable Infection Agustin Arbulu, M.D., Ali Kafi, M.D., Norman W. Thorns, M.D., and Robert F. Wilson, M.D. ABSTRACT Our experience with 25 patients with right-sided
More informationAcute Rejection in the Long-Term Cardiac Transplant Survivor
Acute Rejection in the Long-Term Cardiac Transplant Survivor Clinical Diagnosis, Treatment and Significance By ANTHONY F. GRAHAM, M.D., F.R.C.P., ALAN K. RIDER, M.D., PHILIP K. CAVES, M.B., F.R.C.S., EDWARD
More informationThe diagnosis and treatment of cardiac rejection is
ORIGINAL ARTICLES: CARDIOVASCULAR Routine Surveillance Endomyocardial Biopsy: Late Rejection After Heart Transplantation David A. Heimansohn, MD, Robert J. Robison, MD, John M. Paris III, MD, Robert G.
More informationPost Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ
Post Operative Management in Heart Transplant นพ พ ชร อ องจร ต ศ ลยศาสตร ห วใจและทรวงอก จ ฬาลงกรณ Art of Good Cooking Good Ingredient Good donor + OK recipient Good technique Good team Good timing Good
More informationSystemic lupus erythematosus (SLE): Pleuropulmonary Manifestations
08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,
More informationTwenty-Year Survivors of Heart Transplantation at Stanford University
American Journal of Transplantation 2008; 8: 1769 1774 Wiley Periodicals Inc. Special Article C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society
More informationHeart-Lung Transplantation for Irreversible Pulimonary Hypertension
ORIGINAL ARTICLES Heart-Lung Transplantation for Irreversible Pulimonary Hypertension S. W. Jamieson, M.B., F.R.C.S., E. B. Stinson, M.D., P. E. Oyer, M.D., Ph.D., B. A. Reitz, M.D., J. Baldwin, M.D.,
More informationTDM. Measurement techniques used to determine cyclosporine level include:
TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationINTERNET-BASED HOME MONITORING OF PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION. 2000, 25 patients underwent heart lung (HLT) or bilateral-lung (BLT)
Online Supplement for: INTERNET-BASED HOME MONITORING OF PULMONARY FUNCTION AFTER LUNG TRANSPLANTATION METHODS Patients Between the start of the study in June 1998 and the end of the study in September
More informationEffect of Acute Allograft Rejection on Exercise Hemodynamics in Patients Who
Effect of Acute Allograft Rejection on Exercise Hemodynamics in Patients Who Have Undergone Cardiac Transplantation* John N. Nanas, MD; Maria I. Anastasiou-Nana, MD; Richard B. Sutton, MD; and Theofilos
More informationChemotherapy for Adenocarcinoma and Alveolar Cell Carcinoma
Chemotherapy for Adenocarcinoma and Alveolar Cell Carcinoma of the Lung Scott L. Faulkner, M.D., R. Benton Adkins, Jr., M.D., and Vernon H. Reynolds, M.D. ABSTRACT Ten patients with inoperable or recurrent
More informationListing Form: Heart or Cardiovascular Impairments. Medical Provider:
Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition
More informationWedge Biopsy for Diffuse Lung Diseases
Chapter VI Wedge Biopsy for Diffuse Lung Diseases Wedge biopsy via thoracoscopic biopsy or open lung biopsy is occasionally performed to obtain tissue for the diagnosis of a diffuse lung disease. A wedge
More informationThe first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town
AFRICA CARDIOVASCULAR JOURNAL OF AFRICA Vol 20, No 1, January/February 2009 31 Cardiovascular Historical Review Topics Article The first human heart transplant and further advances in cardiac transplantation
More informationSerum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant
SDC, Patients and Methods Complement-dependent lymphocytotoxic crossmatch test () Serum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant donor-specific CXM was
More informationTrends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014
Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of
More informationThe 1-year survival rate approaches 80% for patients
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Frank A. Pigula, MD, Bartley P. Griffith, MD, Marco A. Zenati, MD, James H. Dauber, MD, Samuel A. Yousem, MD, and Robert J.
More informationPREVENTION AND TREATMENT OF BKV NEPHROPATHY Petra Reinke, Berlin, Germany. Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy
PREVENTION AND TREATMENT OF BKV NEPHROPATHY Petra Reinke, Berlin, Germany Chair: Daniel Abramowicz, Brussels, Belgium Rosanna Coppo, Turin, Italy Prof Petra Reinke Department of Nephrology University Hospital
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationProgression pattern of restrictive allograft syndrome after lung transplantation
http://www.jhltonline.org FEATURED ARTICLES Progression pattern of restrictive allograft syndrome after lung transplantation Masaaki Sato, MD, PhD, a,b David M. Hwang, MD, PhD, a Thomas K. Waddell, MD,
More informationAnalysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
Cardiac and Pulmonary Replacement Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation Infection and rejection remain the greatest threats to the survival
More informationLONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS
LONG-TERM RESULTS OF CARDIAC TRANSPLANTATION IN PATIENTS OLDER THAN SIXTY YEARS Advanced age has traditionally been a contraindication to cardiac transplantation. We have, however, offered cardiac transplantation
More informationcytoimmunological monitoring on blood cells and quantitative birefringence measurements on
J Clin Pathol 1990;43:137-142 Heart Transplantation Centre, Utrecht, Groningen, Department of Clinical Immunology, Diagnostic Laboratory of Clinical Chemistry, Division of Immunopathology of the Departments
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated
More informationUnit II Problem 2 Pathology: Pneumonia
Unit II Problem 2 Pathology: Pneumonia - Definition: pneumonia is the infection of lung parenchyma which occurs especially when normal defenses are impaired such as: Cough reflex. Damage of cilia in respiratory
More informationSESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012
SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I December 5, 2012 FACULTY COPY GOAL: Describe the basic morphologic and pathophysiologic changes in various conditions
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationAntibody-Mediated Rejection in the Lung Allograft. Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305
Antibody-Mediated Rejection in the Lung Allograft Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305 Gerald J Berry, MD Professor of Pathology Stanford University, Stanford, CA
More informationObjectives. Highlight typical feature of TB pericarditis. How to make a diagnosis. How to treat TB pericarditis
Dr. Conteh Objectives Highlight typical feature of TB pericarditis How to make a diagnosis How to treat TB pericarditis New evidence for adjunctive corticosteroid Introduction TB pericarditis occurs in
More informationDescribe regional differences in pulmonary blood flow in an upright person. Describe the major functions of the bronchial circulation
OBJECTIVES Describe regional differences in pulmonary blood flow in an upright person Define zones I, II, and III in the lung, with respect to pulmonary vascular pressure and alveolar pressure Describe
More informationEvolution of Surgical Therapies for End-Stage Cardiopulmonary Failure. Heart Failure at the Shoe XI October 5, 2012
Evolution of Surgical Therapies for End-Stage Cardiopulmonary Failure Heart Failure at the Shoe XI October 5, 2012 Robert S.D. Higgins, MD, MSHA Executive Director, Comprehensive Transplant Center Evolution
More information1988 to January The original diagnoses are shown in table 1. Donor selection
Eur Respir J, 1995, 8, 5 9 DOI: 10.1183/09031936.95.08010005 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Pulmonary reimplantation response
More informationAcute cardiogenic shock with standing-still heart
Acute cardiogenic shock with standing-still heart Ga Yeon Lee April, 21, 2017 Division of cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, South Korea
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine
Specific Basic Standards for Osteopathic Fellowship Training in Pulmonary / Critical Care Medicine American Osteopathic Association and American College of Osteopathic Internists BOT Rev. 2/2011 These
More informationSurgical Technique of Experimental Lung Transplantation in Rabbits
Original Article Surgical Technique of Experimental Lung Transplantation in Rabbits Shigetoshi Yoshida, MD, Yasuo Sekine, MD, Yukio Saitoh, MD, Kazuhiro Yasufuku, MD, Takekazu Iwata, MD, and Takehiko Fujisawa,
More informationLung Allograft Dysfunction
Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to
More informationCyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients
Cyclosporin A in Cardiac Transplantation: Medium-term Results in 62 Patients Mohsin Hakim, F.R.C.S., M.R.C.P., John Wallwork, B.Sc., F.R.C.S., and Terence English, B.Sc., F.R.C.S. ABSTRACT Between March,
More informationThe Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale
The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant
More informationS plantation has become an accepted therapy for endstage
HLA Histocompatibility Affects Cardiac Transplant Rejection and May Provide One Basis for Organ Allocation Verdi J. DiSesa, MD, Paul C. Kuo, MD, Keith A. Horvath, MD, Gilbert H. Mudge, MD, John J. Collins,
More informationCARDIOVASCULAR SURGERY
Volume 107, Number 4 April 1994 The Journal of THORACIC AND CARDIOVASCULAR SURGERY Cardiac and Pulmonary Transplantation Risk factors for graft failure associated with pulmonary hypertension after pediatric
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationINTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION a Society that includes Basic Science, the Failing Heart, and Advanced Lung Disease
International Society of Heart and Lung Transplantation Advisory Statement on the Implications of Pandemic Influenza for Thoracic Organ Transplantation This advisory statement has been produced by the
More informationPart I Study Questions
Part I Study Questions 1. A 59-year-old man with a history of pulmonary embolism diagnosed 2 years ago and treated with warfarin for 6 months is evaluated for progressive dyspnea and bilateral lower extremity
More informationReperfusion Injury Significantly Impacts Clinical Outcome After Pulmonary Transplantation
Reperfusion Injury Significantly Impacts Clinical Outcome After Pulmonary Transplantation Robert C. King, MD, Oliver A. R. Binns, MD, Filiberto Rodriguez, MD, R. Chai Kanithanon, BA, Thomas M. Daniel,
More informationLecture Notes. Chapter 16: Bacterial Pneumonia
Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment
More informationMyocardial Ischemia in Infants
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 8 NUMBER 5 NOVEMBER 1969. * Myocardial Ischemia in Infants Its Role in Three
More informationOntario s Referral and Listing Criteria for Adult Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationSCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW
SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW Lung disease can be a serious complication of scleroderma. The two most common types of lung disease in patients with scleroderma are interstitial
More information(JPC ) Caprine lungs
2011-7-2 (JPC 3133973) Caprine lungs Bat Otgontugs Bovine Pathology Contributor: Natoinal Institute Animal Health, Tsukuba, Japan Signalment: 5-year 3-month old female Japanese native breed goat, (Capra
More informationHYPERSENSITIVITY PNEUMONITIS
HYPERSENSITIVITY PNEUMONITIS A preventable fibrosis MOSAVIR ANSARIE MB., FCCP INTERSTITIAL LUNG DISEASES A heterogeneous group of non infectious, non malignant diffuse parenchymal disorders of the lower
More informationC1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders
C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees
More informationIntruduction PSI MODE OF ACTION AND PHARMACOKINETICS
Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University
More informationValue of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting
Thorax 1983;38:946-95 Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting RICHARD W BUNTON From the Department of Cardiothoracic
More informationJune 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2
June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic
More informationT tation remains high and is reported as 38% [l]. The
Pneumocystis carinii Pneumonia After Heart Transplantation Hideaki Saigenji, MD, Mitsunori Kaneko, MD, Birger Rhenmen, MD, Richard J. Williams, MD, M. Andre Vasu, MD, Timothy B. Icenogle, MD, and Jack
More informationOntario s Referral and Listing Criteria for Adult Heart Transplantation
Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationThe lungs as the site of delayed-type hypersensitivity reactions in guinea pigs
BRIEF COMMUNICATION The lungs as the site of delayed-type hypersensitivity reactions in guinea pigs Terumasa Miyamoto, M.D., and Junzaburo Kobe, M.D. Tokyo, Japan Guinea pigs immunized hy a single intramuscular
More informationClinical Policy: Heart-Lung Transplant Reference Number: CP.MP.132
Clinical Policy: Reference Number: CP.MP.132 Effective Date: 01/18 Last Review Date: 05/18 Coding Implications Revision Log Description Heart-lung transplantation is treatment of choice for patients with
More informationParamedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)
Paramedic Rounds Pre-Hospital Continuous Positive Airway Pressure (CPAP) Morgan Hillier MD Class of 2011 Dr. Mike Peddle Assistant Medical Director SWORBHP Objectives Outline evidence for pre-hospital
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationUse of the Total Artificial Heart in the Failing Fontan Circulation J William Gaynor, M.D.
Use of the Total Artificial Heart in the Failing Fontan Circulation J William Gaynor, M.D. Daniel M. Tabas Endowed Chair in Pediatric Cardiothoracic Surgery at The Children s Hospital of Philadelphia The
More informationCommon things are common, but not always the answer
Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:
More informationPrepared Pulmonary venous Orifice
HOW TO DO IT The Surgical Technique of Heterotopic Heart Transplantation D. Novitzky, M.D., F.C.S.(S.A.), D. K. C. Cooper, M.A., M.B., B.S., Ph.D., F.R.C.S., and C. N. Barnard, M.D., M.Med., M.S., Ph.D.,
More informationSolid Organ Transplantation 1. Chapter 55. Solid Organ Transplant, Self-Assessment Questions
Solid Organ Transplantation 1 Chapter 55. Solid Organ Transplant, Self-Assessment Questions Questions 1 to 9 are related to the following case: A 38-year-old white man is scheduled to receive a living-unrelated
More informationImmunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Immunosuppressants Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Immunosuppressive Agents Very useful in minimizing the occurrence of exaggerated or inappropriate
More informationOntario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria
More informationSteroid-Free Maintenance Immunosuppression After Heart Transplantation
Steroid-Free Maintenance Immunosuppression After Heart Transplantation Timothy E. Oaks, MD, Thomas Wannenberg, MD, Sherry A. Close, BSN, Laura E. Tuttle, BSN, and Neal D. Kon, MD Departments of Cardiothoracic
More informationTB Radiology for Nurses Garold O. Minns, MD
TB Nurse Case Management Salina, Kansas March 31-April 1, 2010 TB Radiology for Nurses Garold O. Minns, MD April 1, 2010 TB Radiology for Nurses Highway Patrol Training Center Salina, KS April 1, 2010
More informationProtecting the Lungs
Protecting the Lungs PGA New York 12/07 Disclosures: Peter Slinger MD, FRCPC University of Toronto 58 y.o. Male, Chronic Gallstone Pancreatitis, Open Cholecystectomy 100 pack/year smoker Dyspnea > 1 block
More informationDefinitions. You & Your New Transplant ` 38
Definitions Acute Short, relatively severe Analgesic Pain medicine Anemia A low number of red blood cells Anesthetic Medication that dulls sensation in order to reduce pain Acute Tubular Necrosis (ATN)
More informationScottish Medicines Consortium
Scottish Medicines Consortium tacrolimus, 5mg/ml concentrate for infusion and 0.5mg, 1mg, 5mg hard capsules (Prograf ) No. (346/07) Astellas Pharma Ltd 12 January 2007 The Scottish Medicines Consortium
More informationERDHEIM-CHESTER DISEASE LUNG & HEART ISSUES
ERDHEIM-CHESTER DISEASE LUNG & HEART ISSUES GIULIO CAVALLI, M.D. INTERNAL MEDICINE AND CLINICAL IMMUNOLOGY IRCCS SAN RAFFAELE HOSPITAL VITA-SALUTE SAN RAFFAELE UNIVERSITY MILAN, ITALY cavalli.giulio@hsr.it
More informationSurgical treatment of bullous lung disease
Surgical treatment of bullous lung disease PD POTGIETER, SR BENATAR, RP HEWITSON, AD FERGUSON Thorax 1981 ;36:885-890 From the Respiratory Clinic, Groote Schuur Hospita', and Departments of Medicine, Anaesthetics,
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationCase Of The Month.(interstitial Granulomatous Dermatitis): An Article From: Skin & Allergy News [HTML] [Digital] By Sherry Boschert READ ONLINE
Case Of The Month.(interstitial Granulomatous Dermatitis): An Article From: Skin & Allergy News [HTML] [Digital] By Sherry Boschert READ ONLINE If you are looking for a ebook Case of the month.(interstitial
More informationSINCE the introduction of Imuran and
Cadaveric Renal Transplantation With Cyclosporin-A and Steroids T. R. Hakala, T. E. Starzl, J. T. Rosenthal, B. Shaw, and S. watsuki SNCE the introduction of muran and prednisone in 1961, and despite the
More informationEmerging Drug List EVEROLIMUS
Generic (Trade Name): Manufacturer: Everolimus (Certican ) Novartis Pharmaceuticals NO. 57 MAY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence: For use with cyclosporine
More informationDr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION
Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC
More informationAtlas of the Vasculitic Syndromes
CHAPTER e40 Atlas of the Vasculitic Syndromes Carol A. Langford Anthony S. Fauci Diagnosis of the vasculitic syndromes is usually based upon characteristic histologic or arteriographic findings in a patient
More informationClinical history. 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Cardiac catheterization: no CAD
CASE 8 Clinical history 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Concentric hypertrophy Hypokinesis of LV-Inf Cardiac catheterization: no CAD Technique
More informationKey Difference - Pleural Effusion vs Pneumonia
Difference Between Pleural Effusion and Pneumonia www.differencebetween.com Key Difference - Pleural Effusion vs Pneumonia Pleural effusion and pneumonia are two conditions that affect our respiratory
More informationRespiratory Pathology. Kristine Krafts, M.D.
Respiratory Pathology Kristine Krafts, M.D. Normal lung: alveolar spaces Respiratory Pathology Outline Acute respiratory distress syndrome Obstructive lung diseases Restrictive lung diseases Vascular
More information1. Discuss the basic pathophysiology of end-stage liver and kidney failure.
TRANSPLANT SURGERY ROTATION (PGY1, 2) A. Medical Knowledge Goal: The resident will achieve a detailed knowledge of the evaluation and treatment of a variety of disease processes. The resident will be exposed
More informationDoes ambroxol confer a protective effect on the lungs in patients undergoing cardiac surgery or having lung resection?
Interactive CardioVascular and Thoracic Surgery 18 (2014) 830 834 doi:10.1093/icvts/ivu061 Advance Access publication 12 March 2014 BEST EVIDENCE TOPIC THORACIC Does ambroxol confer a protective effect
More informationDIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.
DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE Jules B. Puschett, M.D. Diuretic Resistance A clinical circumstance in which patients do not respond to a combination of salt restriction and even large
More informationFever in Lupus. 21 st April 2014
Fever in Lupus 21 st April 2014 Fever in lupus Cause of fever N= 487 % SLE fever 206 42 Infection in SLE 265 54.5 Active SLE and infection 8 1.6 Tumor fever 4 0.8 Miscellaneous 4 0.8 Crucial Question Infection
More informationRestrictive Pulmonary Diseases
Restrictive Pulmonary Diseases Causes: Acute alveolo-capillary sysfunction Interstitial disease Pleural disorders Chest wall disorders Neuromuscular disease Resistance Pathophysiology Reduced compliance
More informationKey Points. Angus DC: Crit Care Med 29:1303, 2001
Sepsis Key Points Sepsis is the combination of a known or suspected infection and an accompanying systemic inflammatory response (SIRS) Severe sepsis is sepsis with acute dysfunction of one or more organ
More informationTolerance Induction in Transplantation
Tolerance Induction in Transplantation Reza F. Saidi, MD, FACS, FICS Assistant Professor of Surgery Division of Organ Transplantation Department of Surgery University of Massachusetts Medical School Percent
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More information06/04/2013 ISHLT. 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013
LUNG TRANSPLANTS The Journal of Heart and Lung Transplantation, 2012 2 International Conference on Respiratory Physiotherapy ARIR Genova, March 21 23, 2013 LUNG TRANSPLANTATION:STATE OF THE ART L. Santambrogio
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationACID/BASE. A. What is her acid-base disorder, what is her anion gap, and what is the likely cause?
These fluid and electrolyte problems are modified from those in a previous textbook for this sequence, Renal Pathophysiology edited by James A. Shayman M.D., Professor of Internal Medicine, University
More informationNONGYNECOLOGICAL CYTOLOGY PULMONARY SPECIMENS (Sputum, Post-Bronchoscopy Sputum, Bronchial Brushings, Bronchial Washings, Bronchoalveolar Lavage)
NONGYNECOLOGICAL CYTOLOGY PULMONARY SPECIMENS (Sputum, Post-Bronchoscopy Sputum, Bronchial Brushings, Bronchial Washings, Bronchoalveolar Lavage) I. Purpose The adequacy of a sputum specimen is determined
More information